{
    "clinical_study": {
        "@rank": "122748", 
        "arm_group": [
            {
                "arm_group_label": "Multimodal", 
                "arm_group_type": "Experimental", 
                "description": "oral Ibuprofen 400mg 4 times daily oral Gabapentin 300mg twice daily oral Paracetamol 1000mg 4 times daily"
            }, 
            {
                "arm_group_label": "Morphine", 
                "arm_group_type": "Active Comparator", 
                "description": "oral Morphine 10mg 4 times daily oral paracetamol 1000mg 4 times daily"
            }
        ], 
        "brief_summary": {
            "textblock": "To test if multimodal analgesia with different analgesic medication offer better pain\n      relief, lesser side effects and is safe compared to conventionel opiod analgesia after\n      cardiac surgery."
        }, 
        "brief_title": "Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery", 
        "completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Analgesia", 
            "Postoperative Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age>18\n\n          -  any cardiac procedure with sternotomy\n\n          -  able to give informed consent\n\n        Exclusion Criteria:\n\n          -  cardiac surgery without sternotomy\n\n          -  peripheral neuropathy\n\n          -  neurological disease\n\n          -  psychiatric illness\n\n          -  history of GI bleeding\n\n          -  chronic pain (i.e. back pain, cancer, arthritis)\n\n          -  serum creatinine  >150 \u03bcmol/l\n\n          -  hepatic disease with elevated liver enzymes (SGPT and SGOT elevated to 1.5 times\n             maximum normal value)\n\n          -  allergic to study medication\n\n          -  alcohol abuse\n\n          -  abuse of narcotics or medication\n\n          -  pregnancy\n\n          -  participation in other clinical trials\n\n          -  insufficient language skills\n\n          -  In addition intensive care unit (ICU) stay for more than 24 hours was used as a\n             pre-defined post randomization exclusion criteria, because prolonged ICU stay and\n             ventilator treatment would interfere with study analgesic protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966172", 
            "org_study_id": "Smerte1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Multimodal", 
                "description": "oral ibuprofen 400mg 4 times daily", 
                "intervention_name": "Ibuprofen", 
                "intervention_type": "Drug", 
                "other_name": "non-selective Non-steroid antiinflammatory drug (NSAID)"
            }, 
            {
                "arm_group_label": "Multimodal", 
                "description": "Oral Gabapentin 300mg twice daily", 
                "intervention_name": "Gabapentin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Morphine", 
                "description": "10 mg morphine orally 4 times daily", 
                "intervention_name": "Morphine", 
                "intervention_type": "Drug", 
                "other_name": "An opiod"
            }, 
            {
                "arm_group_label": [
                    "Multimodal", 
                    "Morphine"
                ], 
                "description": "oral paracetamol 1000mg four times daily", 
                "intervention_name": "Paracetamol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Ibuprofen", 
                "Morphine", 
                "Gabapentin", 
                "Anti-Inflammatory Agents", 
                "Anti-Inflammatory Agents, Non-Steroidal"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.", 
        "lastchanged_date": "October 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "O", 
                    "zip": "2100"
                }, 
                "name": "Rigshospitalet, Copenhagen University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multimodal Opiate-sparing Analgesia Versus Traditional Opiate Based Analgesia After Cardiac Surgery, a Randomized Controlled Trial", 
        "overall_official": [
            {
                "affiliation": "Rigshospitalet, Denmark", 
                "last_name": "Peter Skov Olsen, MD,PhD,DMSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rigshospitalet, Denmark", 
                "last_name": "Sulman Rafiq, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: The Danish National Committee on Biomedical Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "assessement of analgesic effect for the first 4 days after surgery", 
            "measure": "Evaluation of analgesic effect by 11-NRS scale", 
            "safety_issue": "No", 
            "time_frame": "4th postoperative day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966172"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Sulman Rafiq", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Additional analgesic consumption", 
                "safety_issue": "No", 
                "time_frame": "4th postoperative day"
            }, 
            {
                "measure": "Hospital stay in days.", 
                "safety_issue": "No", 
                "time_frame": "days until discharge"
            }, 
            {
                "measure": "Evaluation of side-effects by daily questionnaire", 
                "safety_issue": "No", 
                "time_frame": "4th postoperative day"
            }, 
            {
                "description": "i.e.  Myocardial infarction(MI), postoperative pericardial effusion, heart failure requiring inotropic support , atrial fibrillation.", 
                "measure": "Cardiac complications", 
                "safety_issue": "Yes", 
                "time_frame": "30th postoperative day"
            }, 
            {
                "description": "i.e. cerebral (stroke, bleeding), GI(bleeding), blood component requirements and sternal complications.", 
                "measure": "Other complications", 
                "safety_issue": "Yes", 
                "time_frame": "30th postoperative day"
            }, 
            {
                "description": "Death from all causes.", 
                "measure": "30 day Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "30th postoperative day"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}